Synovics Pharmaceuticals, Inc. Stock

Stocks

SYVC

US87163M1018

Pharmaceuticals

OTC Markets Traded
Market Closed - OTC Markets 18:02:23 13/10/2025 +03 5-day change 1st Jan Change
0.000100 USD -50.00% Intraday chart for Synovics Pharmaceuticals, Inc. -.--% -
3 months+9,900.00%

Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.42M 1.33M 1.22M 2.29M 156M 2.32M 15.55M 6.1M 78.26M 6.16M 6.03M 259M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.03M 6.57M 6.02M 11.33M 774M 11.51M 77.04M 30.24M 388M 30.53M 29.86M 1.28B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
1 day-50.00%
3 months+9,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0
Change 5-day change 1-year change 3-year change Capi.($)
-50.00%-.--%-.--%-.--% 3.65K
-0.52%+3.21%+85.02%+161.12% 1,057B
+0.88%+1.13%+51.13%+49.76% 625B
+0.89%-1.95%+23.73%+63.67% 435B
+0.71%+3.87%+47.45%+38.68% 363B
+0.64%-0.49%+35.39%+40.21% 296B
+0.39%-5.83%+8.64%+9.28% 249B
+1.51%+6.69%+44.34%+62.47% 222B
+3.92%-0.46%-1.21%-44.09% 209B
+1.80%+2.30%+20.79%+65.13% 165B
Average -3.82%+0.78%+31.53%+44.62% 362.08B
Weighted average by Cap. +1.12%+1.22%+48.34%+75.33%

Financials

2007 2008
Net sales 23.47M 20.3M 18.96M 17.39M 32.71M 2.23B 33.23M 222M 87.29M 1.12B 88.12M 86.19M 3.7B 25.96M 22.46M 20.97M 19.24M 36.18M 2.47B 36.76M 246M 96.56M 1.24B 97.48M 95.35M 4.09B
Net income -20.86M -18.04M -16.85M -15.46M -29.07M -1.99B -29.53M -198M -77.59M -995M -78.33M -76.61M -3.29B -4.01M -3.47M -3.24M -2.97M -5.58M -381M -5.67M -37.96M -14.9M -191M -15.04M -14.71M -632M
Net Debt 18.79M 16.25M 15.18M 13.92M 26.19M 1.79B 26.6M 178M 69.89M 896M 70.56M 69.02M 2.96B 6.49M 5.61M 5.24M 4.81M 9.04M 618M 9.19M 61.49M 24.14M 310M 24.37M 23.83M 1.02B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
155
  1. Stock Market
  2. Stocks
  3. SYVC Stock